NTRK2 and breast carcinoma: Such findings were reported in breast cancer, demonstrating that the association of truncated form of TrkB with p75NTR is essential for ligand binding and p75NTR activation and is not inhibited by K252a [12], a tyrosine kinase inhibitor of Trks [37].